In stable MS patients, stopping Ocrevus does not seem to increase the risk of disease activity or disability progression for ...
A clinical trial in China testing ICP-538, a treatment candidate for MS and other autoimmune diseases, has dosed its first healthy volunteer.
During MS Awareness Month, a Groundbreaking Research-and-Care Model Looks Back on 20 Years of Firsts I am eager to see ...
Symptoms, care, and treatment advances ...
The walk brought together individuals, families and supporters from across the community.
People living in Northern Ireland significantly underestimate the impact of healthy lifestyle choices on multiple sclerosis (MS), a new survey by charity Overcoming MS reveals.